Over the past 12 months, Medicus Pharma insiders made no open-market purchases or sales of the stock.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Fund Partners, Lp Velocity | TenPercentOwner | 0 | 64,975 | 64,975 | 29.3% | 21 May, 2025 |
| 2 | Raza Bokhari | Chief Executive Officer | 58,824 | 0 | 58,824 | 26.5% | 08 Sep, 2026 |
| 3 | Carolyn F. Bonner | President And Cfo | 29,790 | 0 | 29,790 | 13.4% | 08 Sep, 2026 |
| 4 | Faisal Mehmud | Chief Medical Officer | 29,412 | 0 | 29,412 | 13.3% | 08 Sep, 2026 |
| 5 | Andrew Alasdair Smith | Chief Operating Officer | 14,709 | 0 | 14,709 | 6.6% | 08 Sep, 2026 |
| 6 | Edward J. Brennan | Chief Scientific Officer | 13,495 | 0 | 13,495 | 6.1% | 08 Sep, 2026 |
| 7 | James P. Quinlan | Chief Financial Officer | 10,566 | 0 | 10,566 | 4.8% | 14 Aug, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 04 Sep, 2026 | Edward J. Brennan | Chief Scientific Officer | Acquired A | 588,235 | $0.17 | $100.29K | 674,735 | Direct |
| 04 Sep, 2026 | Carolyn F. Bonner | President And Cfo | Acquired A | 1,470,588 | $0.17 | $250.74K | 1,489,493 | Direct |
| 04 Sep, 2026 | Andrew Alasdair Smith | Chief Operating Officer | Acquired A | 735,294 | $0.17 | $125.37K | 735,458 | Direct |
| 04 Sep, 2026 | Faisal Mehmud | Chief Medical Officer | Acquired A | 1,470,588 | $0.17 | $250.74K | 1,470,588 | Direct |
| 04 Sep, 2026 | Raza Bokhari | Chief Executive Officer | Acquired A | 2,941,176 | $0.17 | $501.47K | 2,941,176 | Direct |
| 04 Sep, 2026 | Carolyn F. Bonner | President And Cfo | Acquired A | 250,000 | $0.00 | $0 | 250,000 | Direct |
| 04 Sep, 2026 | Faisal Mehmud | Chief Medical Officer | Acquired A | 250,000 | $0.00 | $0 | 250,000 | Direct |
| 04 Sep, 2026 | Raza Bokhari | Chief Executive Officer | Acquired A | 500,000 | $0.00 | $0 | 500,000 | Direct |
| 04 Sep, 2026 | Edward J. Brennan | Chief Scientific Officer | Acquired A | 100,000 | $0.00 | $0 | 100,000 | Direct |
| 04 Sep, 2026 | Andrew Alasdair Smith | Chief Operating Officer | Acquired A | 125,000 | $0.00 | $0 | 125,000 | Direct |
| 03 Jun, 2026 | William Ashton | Director | Acquired A | 50,000 | $0.00 | $0 | 50,000 | Direct |
| 03 Jun, 2026 | Carolyn F. Bonner | President And Cfo | Acquired A | 250,000 | $0.00 | $0 | 250,000 | Direct |
| 03 Jun, 2026 | Raza Bokhari | Chief Executive Officer | Acquired A | 500,000 | $0.00 | $0 | 500,000 | Direct |
| 03 Jun, 2026 | Patrick J Mahaffy | Director | Acquired A | 50,000 | $0.00 | $0 | 50,000 | Direct |
| 03 Jun, 2026 | Edward J. Brennan | Chief Scientific Officer | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 03 Jun, 2026 | Robert J. Ciaruffoli | Director | Acquired A | 50,000 | $0.00 | $0 | 50,000 | Direct |
| 03 Jun, 2026 | Faisal Mehmud | Chief Medical Officer | Acquired A | 250,000 | $0.00 | $0 | 250,000 | Direct |
| 03 Jun, 2026 | Barry Fishman | Director | Acquired A | 50,000 | $0.00 | $0 | 50,000 | Direct |
| 03 Jun, 2026 | Sara R. May | Director | Acquired A | 50,000 | $0.00 | $0 | 50,000 | Direct |
| 03 Jun, 2026 | Andrew Alasdair Smith | Chief Operating Officer | Acquired A | 200,000 | $0.00 | $0 | 200,000 | Direct |